All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

502

Reset

502 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • DW5421APhase 31 trial

    Daewon Pharmaceutical Co., Ltd. · Primary Hypercholesterolemia, Mixed Dyslipidemia

  • DW5421BPhase 31 trial

    Daewon Pharmaceutical Co., Ltd. · Primary Hypercholesterolemia, Mixed Dyslipidemia

  • DWC202313Phase 31 trial

    Daewoong Pharmaceutical Co. LTD. · Essential Hypertension

  • DWC202404Phase 31 trial

    Daewoong Pharmaceutical Co. LTD. · Hypertension, Essential Hypertension

  • DWC202405Phase 31 trial

    Daewoong Pharmaceutical Co. LTD. · Essential Hypertension

  • DWC202518Phase 31 trial

    Daewoong Pharmaceutical Co. LTD. · T2DM (Type 2 Diabetes Mellitus)

  • F027Phase 31 trial

    Shandong New Time Pharmaceutical Co., LTD · Type 2 Diabetes (T2DM)

  • FDC laroprovstatPhase 31 trial

    AstraZeneca · Hypercholesterolemia

  • FDY-5301Phase 31 trial

    Faraday Pharmaceuticals, Inc. · Acute Myocardial Infarction, STEMI, Percutaneous Coronary Revascularization

  • FimasartanPhase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension

  • HCP1803-4Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Hypertension

  • HDM1702Phase 31 trial

    Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · Obesity Control

  • HGP2304-1Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Hypertension

  • HGP2304-2Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Hypertension

  • HPP2002-1Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Hypertension

  • HPP2003-3Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Hypertension

  • I004Phase 31 trial

    Amphastar Pharmaceuticals, Inc. · Pharmacokinetics, Pharmacodynamics, Insulin Aspart

  • IBI306Phase 31 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia

  • INCA033989Phase 31 trial

    Incyte · Essential Thrombocythemia

  • INS068Phase 31 trial

    Jiangsu HengRui Medicine Co., Ltd. · Type 2 Diabetes

  • Roche (Genentech) · Diabetic Macular Edema

  • JW0104Phase 31 trial

    JW Pharmaceutical · Hypertension, Dyslipidemia

  • JW0108Phase 31 trial

    JW Pharmaceutical · Dyslipidemia

  • JX10Phase 31 trial

    Corxel Pharmaceuticals · Acute Ischemic Stroke

  • L606Treprostinil LiposomePhase 31 trial

    Liquidia Technologies, Inc. · Pulmonary Hypertension Due to Lung Disease (Disorder)

  • LID104Phase 31 trial

    EMS · Type 2 Diabetes Mellitus

  • Novo Nordisk · Overweight, Obesity, Type 2 Diabetes

  • MDR-001Phase 31 trial

    MindRank AI Ltd · Overweight or Obesity

  • NoiiglutidePhase 31 trial

    Jiangsu HengRui Medicine Co., Ltd. · Type 2 Diabetes

  • Supergene, LLC · Ischemic Stroke, Acute

  • OPC-1085ELPhase 31 trial

    Otsuka · Open Angle Glaucoma or Ocular Hypertension

  • OtaplimastatSP-8203Phase 31 trial

    Shin Poong Pharmaceutical Co. Ltd. · Ischemic Stroke

  • PrusogliptinPhase 31 trial

    CSPC Ouyi Pharmaceutical Co., Ltd. · Type 2 Diabetes

  • QLG1091Phase 31 trial

    Qilu Pharmaceutical Co., Ltd. · Type 2 Diabetes

  • QR12000Phase 31 trial

    Wuhan Createrna Science and Technology Co., Ltd · Essential Hypertension

  • RC28-EPhase 31 trial

    RemeGen Co., Ltd. · Diabetic Macular Edema (DME), wAMD

  • Recombinant Human ProurokinaserhPro-UKPhase 31 trial

    Tasly Biopharmaceuticals Co., Ltd. · Acute Ischemic Stroke AIS

  • RilogrotugPhase 31 trial

    AVEO Pharmaceuticals, Inc. · Cachexia; Cancer, Cachexia, Cachexia-Anorexia Syndrome

  • RLD2001-2Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Hypertension

  • RLD2209-1Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Hypertension

  • RLD2209-2Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Hypertension

  • SHPL-49Phase 31 trial

    Shanghai Hutchison Pharmaceuticals Limited · Acute Ischemic Stroke

  • SIM0811Phase 31 trial

    Jiangsu Simcere Pharmaceutical Co., Ltd. · Acute Ischemic Stroke AIS

  • SYH9056Phase 31 trial

    CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Mild-to-moderate Essential Hypertension

  • TCA108Phase 31 trial

    EMS · Hypertension

  • THP-00101Forxiga Tab.Phase 31 trial

    THPharm Corp. · Type 2 Diabetes, Hypertension

  • THP-00102Micardis Tab., THP-00103Phase 31 trial

    THPharm Corp. · Type 2 Diabetes, Hypertension

  • THP-00104Phase 31 trial

    THPharm Corp. · Type 2 Diabetes, Hypertension

  • THP-00105Phase 31 trial

    THPharm Corp. · Type 2 Diabetes, Hypertension

  • THP-00106Phase 31 trial

    THPharm Corp. · Type 2 Diabetes, Hypertension

NewerPage 5 of 11Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.